| |
| |
| Preface | |
| |
| |
| |
| Introduction | |
| |
| |
| |
| Introductory remarks | |
| |
| |
| |
| The Concept of the Theraputic Team | |
| |
| |
| |
| The concept of the therapeutic team | |
| |
| |
| |
| The view of a pharmacist | |
| |
| |
| |
| The view of a physician | |
| |
| |
| |
| The view of a nurse | |
| |
| |
| |
| The view of the clinical pharmacologist | |
| |
| |
| |
| The view of an academic | |
| |
| |
| |
| Practice of the Therapeutic Team: Parenteral Nutrition | |
| |
| |
| |
| Parenteral nutrition - the team approach in a general hospital | |
| |
| |
| |
| Long-term follow-up in total parenteral nutrition | |
| |
| |
| |
| Total parenteral nutrition of children at the State University Hospital of Copenhagen | |
| |
| |
| |
| Compatibility of two different fat emulsions with amino-acids, carbohydrate and electrolytes in parenteral nutrition mixtures | |
| |
| |
| |
| Esophagus cancer and parenteral nutrition: postoperative complications and P. N. I. relationship. Preliminary study | |
| |
| |
| |
| Oncology | |
| |
| |
| |
| Central nervous system prohylaxis of acute lymphoblastic leukemia with methotrexate | |
| |
| |
| |
| The treatment protocols of acute lymphoblastic leukemia in children | |
| |
| |
| |
| Guidelines for the safe handling of minibags | |
| |
| |
| |
| Centralization of preparation of cytotoxic drugs in the central pharmacy: one year of experience | |
| |
| |
| |
| Progress in the management of high dose methotrexate | |
| |
| |
| |
| Parmacokinetics of cytosine arabinoside in leukemic patients with normal and impaired hepatic functions, preliminary results | |
| |
| |
| |
| |
| |
| |
| The operation of a therapeutic team in dermatology | |
| |
| |
| |
| Epilepsy | |
| |
| |
| |
| Team treatment of epilepsy | |
| |
| |
| |
| Practices of the therapeutic team in epilepsy | |
| |
| |
| |
| Interdisciplinary approach to the treatment of epilepsy | |
| |
| |
| |
| The role of clinical pharmacist in the monitoring of antiepileptic therapy in clinics with ambulant patients, our experience with 45 patients | |
| |
| |
| |
| Internal Medicine - Rheumatology | |
| |
| |
| |
| An approach to the therapeutic strategy in rheumatoid arthritis. Adverse reactions to penicillamine-like drugs used in the treatment of rheumatoid arthritis | |
| |
| |
| |
| Nuclear Medicine | |
| |
| |
| |
| The nuclear medicine team | |
| |
| |
| |
| Practice of the nuclear medicine therapeutic team: the role of the physician | |
| |
| |
| |
| Practice of the nuclear medicine therapeutic team: the role of the physicist | |
| |
| |
| |
| Practice of the nuclear medicine therapeutic team: the role of the radiotherapist | |
| |
| |
| |
| Drug Selection | |
| |
| |
| |
| Collaboration in drug selection - preparing the London Hospital Formulary 1982 - guide to the prescribing of medicines: introduction | |
| |
| |
| |
| A clinician's view on the team approach to drug selection | |
| |
| |
| |
| A pharmacists view on the team approach to drug selection | |
| |
| |
| |
| Conclusion | |
| |
| |
| |
| Restrictive formulary management with consequences for the treatment of individual patients | |
| |
| |
| |
| Changes in patterns of analgesic use | |
| |
| |
| |
| Pharmacokinetics, Dialysis, IV. Therapy | |
| |
| |
| |
| Clinical pharmacy improvement and interrelation with therapeutci team | |
| |
| |
| |
| Clinical pharmacist participation in a clinical trial - treatment of congestive heart failure | |
| |
| |
| |
| Metronidazole plasma levels after I | |
| |
| |
| |
| Individual factors influencing aminoglycoside serum levels | |
| |
| |
| |
| Monitoring theophylline plasma levels | |
| |
| |
| |
| Comparison of four pharmacokinetic methods for individualizing phenytoin dosage | |
| |
| |
| |
| Use of a calculator program for individualized estimation of pheyoin kinetic parameters by a least-squares technique | |
| |
| |
| |
| On the importance of regular Al determination in patients on regular hemodialysis (RHD) | |
| |
| |
| |
| Manufacture of dialysis concentrate at the level of a hospital | |
| |
| |
| |
| Hospital preparation of injectable drugs by means of a multi-additive pump | |
| |
| |
| |
| How to detect physico-chemical incompatabilities in IV. admixtures | |
| |
| |
| |
| Preparation of an enema containing metaminosalicylic acid | |